SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $457,780 | -54.7% | 763,220 | -1.8% | 0.00% | – |
| Q2 2023 | $1,010,277 | -63.8% | 777,136 | -51.0% | 0.00% | – |
| Q1 2023 | $2,791,240 | -16.2% | 1,585,932 | +49.5% | 0.00% | – |
| Q4 2022 | $3,332,078 | -37.9% | 1,061,171 | -3.0% | 0.00% | -100.0% |
| Q3 2022 | $5,363,000 | -8.4% | 1,094,249 | -22.6% | 0.00% | 0.0% |
| Q2 2022 | $5,856,000 | +17.3% | 1,414,525 | +64.7% | 0.00% | 0.0% |
| Q1 2022 | $4,991,000 | -48.4% | 858,965 | -33.4% | 0.00% | 0.0% |
| Q4 2021 | $9,673,000 | +6.8% | 1,289,584 | +28.2% | 0.00% | 0.0% |
| Q3 2021 | $9,061,000 | -15.1% | 1,005,755 | +12.9% | 0.00% | 0.0% |
| Q2 2021 | $10,667,000 | +19.2% | 891,147 | +24.7% | 0.00% | 0.0% |
| Q1 2021 | $8,951,000 | -29.6% | 714,372 | -12.4% | 0.00% | -50.0% |
| Q4 2020 | $12,722,000 | +300.8% | 815,255 | +142.7% | 0.00% | +100.0% |
| Q3 2020 | $3,174,000 | -11.4% | 335,848 | -16.0% | 0.00% | 0.0% |
| Q2 2020 | $3,584,000 | +42.3% | 399,947 | +1.2% | 0.00% | 0.0% |
| Q1 2020 | $2,518,000 | -63.1% | 395,329 | -51.5% | 0.00% | -50.0% |
| Q4 2019 | $6,820,000 | -5.6% | 814,691 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $7,224,000 | +58.5% | 798,236 | +88.6% | 0.00% | +100.0% |
| Q2 2019 | $4,558,000 | -10.0% | 423,301 | -20.3% | 0.00% | 0.0% |
| Q1 2019 | $5,065,000 | -20.7% | 530,968 | -4.6% | 0.00% | -50.0% |
| Q4 2018 | $6,387,000 | -36.4% | 556,425 | -6.1% | 0.00% | -33.3% |
| Q3 2018 | $10,049,000 | -22.7% | 592,793 | -35.2% | 0.00% | -25.0% |
| Q2 2018 | $12,996,000 | -44.9% | 915,183 | -26.2% | 0.00% | -42.9% |
| Q1 2018 | $23,574,000 | +240.3% | 1,240,739 | +193.7% | 0.01% | +250.0% |
| Q4 2017 | $6,928,000 | -34.5% | 422,397 | -40.1% | 0.00% | -33.3% |
| Q3 2017 | $10,577,000 | +202.8% | 705,124 | +77.6% | 0.00% | +200.0% |
| Q2 2017 | $3,493,000 | +8.8% | 396,976 | -35.7% | 0.00% | – |
| Q1 2017 | $3,210,000 | +27.0% | 617,410 | -25.5% | 0.00% | – |
| Q4 2016 | $2,528,000 | +64.2% | 829,100 | +149.3% | 0.00% | -100.0% |
| Q3 2016 | $1,540,000 | -15.0% | 332,634 | +6.3% | 0.00% | 0.0% |
| Q2 2016 | $1,812,000 | -8.7% | 312,911 | -4.6% | 0.00% | 0.0% |
| Q1 2016 | $1,984,000 | -37.1% | 327,993 | -5.0% | 0.00% | 0.0% |
| Q4 2015 | $3,152,000 | +40.8% | 345,344 | -13.0% | 0.00% | 0.0% |
| Q3 2015 | $2,239,000 | -49.5% | 396,869 | -0.7% | 0.00% | -50.0% |
| Q2 2015 | $4,433,000 | -34.6% | 399,704 | -7.6% | 0.00% | 0.0% |
| Q1 2015 | $6,781,000 | +0.5% | 432,484 | -2.5% | 0.00% | 0.0% |
| Q4 2014 | $6,746,000 | +28.9% | 443,554 | -8.6% | 0.00% | 0.0% |
| Q3 2014 | $5,232,000 | -24.1% | 485,113 | +7.4% | 0.00% | -33.3% |
| Q2 2014 | $6,895,000 | -21.4% | 451,569 | -6.9% | 0.00% | -25.0% |
| Q1 2014 | $8,774,000 | +52.4% | 485,275 | +17.1% | 0.00% | +100.0% |
| Q4 2013 | $5,756,000 | +36.2% | 414,363 | +2.8% | 0.00% | 0.0% |
| Q3 2013 | $4,225,000 | -9.7% | 402,917 | -32.8% | 0.00% | 0.0% |
| Q2 2013 | $4,681,000 | – | 599,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |